Vascular Technology, Incorporated Appoints David Pierce to Board of Directors

Pierce brings more than 30 years of experience in medical device and healthcare technology markets

NASHUA, N.H.--(BUSINESS WIRE)--Vascular Technology, Incorporated (“VTI” or the “Company”), a medical device company specializing in the development, manufacturing and sale of surgical devices, today announced the appointment of David Pierce to its Board of Directors.

Pierce brings more than three decades of experience leading innovation, transformation and sustainable growth across global medical device and healthcare technology markets. He currently serves on the boards of Neuraptive Therapeutics, EvoEndo, Inc., and Mirai Medical. Previously, he served as Executive Vice President and President of the $3.7 billion MedSurg Group at Boston Scientific, where he led enterprise-scale integration, M&A value realization and category leadership.

“David brings extensive industry experience and valuable expertise in areas where VTI is looking to expand,” said Lars Marcher, Executive Chairman of Vascular Technology, Inc. “His insights will be instrumental as we pursue new growth opportunities and strengthen our direct relationships with customers.”

“David has spent his career combining strategic discipline with innovation in highly critical and regulated markets,” said Greg Groenke, Chief Executive Officer of Vascular Technology, Inc. “His experience helping medical device businesses scale will be a valuable addition to our board as we continue to execute VTI’s long-term strategy.”

Innovation across the surgical field, including advances in endoscopic therapies, are creating new opportunities for VTI’s specialized devices. Pierce’s appointment reflects the Company’s continued investment in the leadership and operational capabilities needed to scale and serve evolving customer needs. His appointment follows VTI’s combination with Parks Medical last year, another important step in strengthening the Company’s capacity, reach and commitment to customer service.

Pierce earned an MBA from Boston University and a Bachelor of Science in Business Administration from Norwich University.

ABOUT VASCULAR TECHNOLOGY, INCORPORATED

Vascular Technology, Incorporated is a medical device company specializing in the development, manufacture, and sale of surgical devices, including Intraoperative Doppler Systems and Surgical Suction Irrigation Systems. The Company provides products that are utilized across multiple surgical specialties, including vascular, reconstructive, urology, GI endoscopy, neuro, and robotic surgery. VTI continuously strives to enhance its existing products, as well as develop new products to meet the evolving needs of surgeons. VTI is ISO 13485 Certified and FDA Registered.

For more information, please visit vti-online.com.